Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder

References

• FaraoneSVSergeantJGillbergCBiedermanJThe world wide prevalence of ADHD: is it an American condition?World Psychiatry2210411316946911
   PubMedGoogle Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edArlington, VAAmerican Psychiatric Association2013
   Google Scholar
• ArnstenAFCatecholamine and second messenger influences on prefrontal cortical networks of “representational knowledge”: a rational bridge between genetics and the symptoms of mental illnessCereb Cortex200717Suppl 1i6i1517434919
   PubMed Web of Science ®Google Scholar
• ParkLNiggJTWaldmanIDAssociation and linkage of α-2A adrenergic receptor gene polymorphisms with childhood ADHDMol Psychiatry200510657258015520832
   PubMed Web of Science ®Google Scholar
• LevyFDopamine vs noradrenaline: inverted-U effects and ADHD theoriesAust N Z J Psychiatry200943210110819153917
   PubMed Web of Science ®Google Scholar
• LevyFStimulant side effects and inverted-U: implications for ADHD guidelinesAust N Z J Psychiatry2013a47321722122689336
   PubMed Web of Science ®Google Scholar
• ArnstenAFTDudleyAGMethylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity DisorderBehav Brain Funct200511215916700
   PubMed Web of Science ®Google Scholar
• GamoNJWangMArnstenAFTMethylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptorsJ Am Acad Child Adolesc Psychiatry201049101011102320855046
   PubMed Web of Science ®Google Scholar
• CarboniECadedduRCartaARRole of prefrontal cortex dopamine and noradrenaline circuitry in addictionBelinDAddictions: From Pathophysiology to TreatmentRijeka, CroatiaInTech2012129168
   Google Scholar
• VijayraghavanSWangMBirnbaumSGWilliamsGVArnstenAFInverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memoryNat Neurosci200710337638417277774
   PubMed Web of Science ®Google Scholar
• BilderRMVolavkaJLachmanHMGraceAAThe catechol- O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypesNeuropsychopharmacology200429111943196115305167
   PubMed Web of Science ®Google Scholar
• KeelerJFPretsellDORobbinsTWFunctional implications of dopamine D1 vs D2 receptors: A ‘prepare and select’ model of the striatal direct vs indirect pathwaysNeuroscience2014282C15617525062777
   PubMed Web of Science ®Google Scholar
• SurmeierDJDingJDayMWangZShenWD1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neuronsTrends Neurosci200730522823517408758
   PubMed Web of Science ®Google Scholar
• AlbinRLYoungABPenneyJBThe functional anatomy of basal ganglia disordersTrends Neurosci198912103663752479133
   PubMed Web of Science ®Google Scholar
• Trantham-DavidsonHNeelyLCLavinASeamansJKMechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortexJ Neurosci20042447106521065915564581
   PubMed Web of Science ®Google Scholar
• HillMAnneyRJGillMHawiZFunctional analysis of intron 8 and 3′ UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variantsPharmacogenomics J201010544244720029387
   PubMed Web of Science ®Google Scholar
• CookEHJrSteinMAKrasowskiMDAssociation of attention-deficit disorder and the dopamine transporter geneAm J Hum Genet19955649939987717410
   PubMed Web of Science ®Google Scholar
• GillMDalyGHeronSHawiZFitzgeraldMConfirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphismMol Psychiatry1997243113139246671
   PubMed Web of Science ®Google Scholar
• WaldmanIDRoweDCAbramowitzAAssociation and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severityAm J Hum Genet1998636176717769837830
   PubMed Web of Science ®Google Scholar
• BellgroveMAHawiZKirleyAGillMRobertsonIHDissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotypeNeuropsychologia2005a43131847185716168728
   PubMed Web of Science ®Google Scholar
• ManlyTOwenAMMcAvinueLEnhancing the sensitivity of a sustained attention task to frontal damage: convergent clinical and functional imaging evidenceNeurocase20039434034912925947
   PubMed Web of Science ®Google Scholar
• BellgroveMAHawiZKirleyAFitzgeraldMGillMRobertsonIHAssociation between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorderNeuropsychopharmacology200530122290229716123773
   PubMed Web of Science ®Google Scholar
• TomasiDVolkowNDWangRDopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attentionPLoS ONE200946e610219564918
   PubMed Web of Science ®Google Scholar
• KambeitzJRomanosMEttingerUMeta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHDPharmacogenomics J2014141778423588108
   PubMed Web of Science ®Google Scholar
• BraetWJohnsonKATobinCTfMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHDNeuropsychologia20114971641165021232548
   PubMed Web of Science ®Google Scholar
• CumminsTDHawiZHockingJDopamine transporter genotype predicts behavioural and neural measures of response inhibitionMol Psychiatry201217111086109221876545
   PubMed Web of Science ®Google Scholar
• KimBNKimJWCumminsTDRNorepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorderJ Clin Psychopharmacol201333335636223609393
   PubMed Web of Science ®Google Scholar
• HanDDGuHHComparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugsBMC Pharmacol200661616515684
   PubMedGoogle Scholar
• LevyFWimalaweeraSMoulCBrennanJDaddsMRDopamine receptors and the pharmacogenetics of side-effects of stimulant treatment for attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201323642342523952191
   PubMed Web of Science ®Google Scholar
• SteinMAWaldmanINewcornJBishopJKittlesRCookEHJrDopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201424523824424813374
   PubMed Web of Science ®Google Scholar
• SpencerTJBiedermanJFaraoneSVFunctional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjectsBiol Psychiatry2013742848923273726
   PubMed Web of Science ®Google Scholar
• MarkowitzJSZhuH-JPatrickKSIsopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liabilityJ Child Adolesc Psychopharmacol2013231064865424261661
   PubMed Web of Science ®Google Scholar
• PotterASNewhousePAEffects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorderPsychopharmacology (Berl)2004176218219415083253
   PubMed Web of Science ®Google Scholar
• LevinEDMcClernonFJRezvaniAHNicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localizationPsychopharmacology (Berl)20061843–452353916220335
   PubMed Web of Science ®Google Scholar
• LevinEDChristopherNCPersistence of nicotinic agonist RJR 2403 induced working memory improvement in ratsDrug Dev Res200255297103
   Web of Science ®Google Scholar
• LevinEDBettegowdaCBlosserJGordonJAR-R17779, and alpha7 nicotinic agonist, improves learning and memory in ratsBehav Pharmacol1999106–767568010780509
   PubMed Web of Science ®Google Scholar
• WilensTEBiedermanJSpencerTJA pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorderAm J Psychiatry1999156121931193710588407
   PubMed Web of Science ®Google Scholar